Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato

Detalhes bibliográficos
Autor(a) principal: Elito Junior, Julio [UNIFESP]
Data de Publicação: 1998
Outros Autores: Reichmann, André [UNIFESP], Nakamura, Mary Uchiyama [UNIFESP], Camano, Luiz [UNIFESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S0100-72031998000300002
http://repositorio.unifesp.br/handle/11600/605
Resumo: A prospective study was performed with 42 patients with unruptured ectopic pregnancy, which intended to elaborate an index to orient the systemic treatment with the administration of a single intramuscular dose of methotrexate (50 mg/m²). Patients were monitored with beta-hCG titers on days 1, 4 and 7 after the methotrexate. When the titers of beta-hCG declined more than 15%, between days 4 and 7 after methotrexate, the patients were discharged and had an outpatient follow-up monitored with beta-hCG titers weekly until the titers were less than 5 mIU/ml, which represents success of the treatment. We prepared an index for the systemic treatment with methotrexate, with five parameters: (1) initial titers of beta-hCG; (2) aspects of the image at ultrasound (hematosalpinx, gestational sac, live embryo); (3) size of the mass; (4) free fluid in cul-de-sac; (5) collor doppler. Each parameter received a grade from 0 to 2. Grade 0 represented bad prognosis, favorable parameters received grade 2 and borderline parameters received grade one. The success rate with a single dose of methotrexate was 69.0% (29/42). The color doppler was performed in 20 of the 42 patients; in this group of 20 patients the success rate was 75.0% (15/20). In the 22 patients who were not submitted to the color doppler, the average grade of the score in the successful cases was 6.6, and in the unsuccessful it was 3.1. In the group who underwent the doppler (20 patients) the average was 7.9 in the successful cases and 4.2 in the cases that failed. In the present study the cut-off grade was 5, for most of the patients with grades above 5 had a successful treatment (15/16 - 93.75%), while grades equal or below 5 failed. The score will help to indicate the best cases for the medical treatment. We do not advise the treatment when the grade is equal or below 5. Therefore, we can predict a good evolution of the treatment when the grade is above five.
id UFSP_ec28dbf585736b7b28925ca030e97a8c
oai_identifier_str oai:repositorio.unifesp.br/:11600/605
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexatoIndex for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexateEctopic pregnancyMethotrexateChemotherapyGravidez EctópicaMetotrexatoQuimioterapiaA prospective study was performed with 42 patients with unruptured ectopic pregnancy, which intended to elaborate an index to orient the systemic treatment with the administration of a single intramuscular dose of methotrexate (50 mg/m²). Patients were monitored with beta-hCG titers on days 1, 4 and 7 after the methotrexate. When the titers of beta-hCG declined more than 15%, between days 4 and 7 after methotrexate, the patients were discharged and had an outpatient follow-up monitored with beta-hCG titers weekly until the titers were less than 5 mIU/ml, which represents success of the treatment. We prepared an index for the systemic treatment with methotrexate, with five parameters: (1) initial titers of beta-hCG; (2) aspects of the image at ultrasound (hematosalpinx, gestational sac, live embryo); (3) size of the mass; (4) free fluid in cul-de-sac; (5) collor doppler. Each parameter received a grade from 0 to 2. Grade 0 represented bad prognosis, favorable parameters received grade 2 and borderline parameters received grade one. The success rate with a single dose of methotrexate was 69.0% (29/42). The color doppler was performed in 20 of the 42 patients; in this group of 20 patients the success rate was 75.0% (15/20). In the 22 patients who were not submitted to the color doppler, the average grade of the score in the successful cases was 6.6, and in the unsuccessful it was 3.1. In the group who underwent the doppler (20 patients) the average was 7.9 in the successful cases and 4.2 in the cases that failed. In the present study the cut-off grade was 5, for most of the patients with grades above 5 had a successful treatment (15/16 - 93.75%), while grades equal or below 5 failed. The score will help to indicate the best cases for the medical treatment. We do not advise the treatment when the grade is equal or below 5. Therefore, we can predict a good evolution of the treatment when the grade is above five.Foi realizado estudo longitudinal em 42 pacientes com diagnóstico de gravidez ectópica íntegra, com o intuito de se elaborar um índice orientador do uso sistêmico de metotrexato em dose única (50 mg/m²) por via intramuscular. O acompanhamento se fez através de dosagens de beta-hCG (fração beta do hormônio gonadotrópico coriônico) realizadas no 1º, 4º e 7º dias após o emprego do quimioterápico. Quando ocorreu queda de 15% ou mais nos títulos de beta-hCG, apurados no 4º e no 7º dia, as pacientes receberam alta hospitalar e seguimento ambulatorial com dosagens semanais de beta-hCG até que se atingissem níveis inferiores a 5 mUI/ml. Foi elaborado um índice orientador do tratamento sistêmico com metotrexato baseado nos seguintes parâmetros: (1) valores iniciais de beta-hCG; (2) aspecto da imagem à ultra-sonografia (hematossalpinge, anel tubário, embrião vivo); (3) maior diâmetro da massa anexial; (4) quantidade de líquido livre; (5) fluxo vascular medido por meio do doppler colorido. Cada parâmetro recebeu pontuação de 0 a 2. A nota zero significa elemento de mau prognóstico, a nota dois indica parâmetros favoráveis e a nota um, situações intermediárias. O índice de sucesso com dose única foi de 69,0% (29/42 pacientes). A ultra-sonografia transvaginal com doppler colorido foi realizada em 20 das 42 pacientes do estudo. Neste grupo de 20 pacientes o sucesso do tratamento ocorreu em 75,0% dos casos (15/20). Entre as 22 pacientes que não foram avaliadas com doppler colorido a média das notas do índice nos casos de sucesso foi de 6,6, nas de insucesso 3,1. No grupo de pacientes avaliadas por doppler (20 pacientes) as médias foram de 7,9 (sucesso) e 4,2 (fracasso). No presente estudo a nota de corte foi estabelecida levando-se em conta o valor abaixo do qual o tratamento não foi efetivo e correspondeu a cinco, pois 93,75% das pacientes com nota superior a 5 evoluíram com sucesso (15/16), ao passo que notas inferiores ou iguais a cinco estiveram todas relacionadas com o fracasso do tratamento. O índice orientador ajuda-nos a indicar os melhores casos para o tratamento medicamentoso. Não o aconselhamos, portanto, quando a nota for inferior ou igual a cinco; por outro lado, podemos predizer boa evolução do tratamento, quando a nota for superior a cinco.Universidade Federal de São Paulo (UNIFESP) EPM Departamento de Diagnóstico por ImagemUNIFESP, EPM, Depto. de Diagnóstico por ImagemSciELOFederação Brasileira das Sociedades de Ginecologia e ObstetríciaUniversidade Federal de São Paulo (UNIFESP)Elito Junior, Julio [UNIFESP]Reichmann, André [UNIFESP]Nakamura, Mary Uchiyama [UNIFESP]Camano, Luiz [UNIFESP]2015-06-14T13:24:43Z2015-06-14T13:24:43Z1998-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion127-135application/pdfhttp://dx.doi.org/10.1590/S0100-72031998000300002Revista Brasileira de Ginecologia e Obstetrícia. Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, v. 20, n. 3, p. 127-135, 1998.10.1590/S0100-72031998000300002S0100-72031998000300002.pdf0100-7203S0100-72031998000300002http://repositorio.unifesp.br/handle/11600/605porRevista Brasileira de Ginecologia e Obstetríciainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T21:58:14Zoai:repositorio.unifesp.br/:11600/605Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T21:58:14Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
Index for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate
title Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
spellingShingle Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
Elito Junior, Julio [UNIFESP]
Ectopic pregnancy
Methotrexate
Chemotherapy
Gravidez Ectópica
Metotrexato
Quimioterapia
title_short Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
title_full Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
title_fullStr Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
title_full_unstemmed Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
title_sort Índice orientador do tratamento sistêmico da gravidez ectópica íntegra com dose única de metotrexato
author Elito Junior, Julio [UNIFESP]
author_facet Elito Junior, Julio [UNIFESP]
Reichmann, André [UNIFESP]
Nakamura, Mary Uchiyama [UNIFESP]
Camano, Luiz [UNIFESP]
author_role author
author2 Reichmann, André [UNIFESP]
Nakamura, Mary Uchiyama [UNIFESP]
Camano, Luiz [UNIFESP]
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Elito Junior, Julio [UNIFESP]
Reichmann, André [UNIFESP]
Nakamura, Mary Uchiyama [UNIFESP]
Camano, Luiz [UNIFESP]
dc.subject.por.fl_str_mv Ectopic pregnancy
Methotrexate
Chemotherapy
Gravidez Ectópica
Metotrexato
Quimioterapia
topic Ectopic pregnancy
Methotrexate
Chemotherapy
Gravidez Ectópica
Metotrexato
Quimioterapia
description A prospective study was performed with 42 patients with unruptured ectopic pregnancy, which intended to elaborate an index to orient the systemic treatment with the administration of a single intramuscular dose of methotrexate (50 mg/m²). Patients were monitored with beta-hCG titers on days 1, 4 and 7 after the methotrexate. When the titers of beta-hCG declined more than 15%, between days 4 and 7 after methotrexate, the patients were discharged and had an outpatient follow-up monitored with beta-hCG titers weekly until the titers were less than 5 mIU/ml, which represents success of the treatment. We prepared an index for the systemic treatment with methotrexate, with five parameters: (1) initial titers of beta-hCG; (2) aspects of the image at ultrasound (hematosalpinx, gestational sac, live embryo); (3) size of the mass; (4) free fluid in cul-de-sac; (5) collor doppler. Each parameter received a grade from 0 to 2. Grade 0 represented bad prognosis, favorable parameters received grade 2 and borderline parameters received grade one. The success rate with a single dose of methotrexate was 69.0% (29/42). The color doppler was performed in 20 of the 42 patients; in this group of 20 patients the success rate was 75.0% (15/20). In the 22 patients who were not submitted to the color doppler, the average grade of the score in the successful cases was 6.6, and in the unsuccessful it was 3.1. In the group who underwent the doppler (20 patients) the average was 7.9 in the successful cases and 4.2 in the cases that failed. In the present study the cut-off grade was 5, for most of the patients with grades above 5 had a successful treatment (15/16 - 93.75%), while grades equal or below 5 failed. The score will help to indicate the best cases for the medical treatment. We do not advise the treatment when the grade is equal or below 5. Therefore, we can predict a good evolution of the treatment when the grade is above five.
publishDate 1998
dc.date.none.fl_str_mv 1998-04-01
2015-06-14T13:24:43Z
2015-06-14T13:24:43Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0100-72031998000300002
Revista Brasileira de Ginecologia e Obstetrícia. Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, v. 20, n. 3, p. 127-135, 1998.
10.1590/S0100-72031998000300002
S0100-72031998000300002.pdf
0100-7203
S0100-72031998000300002
http://repositorio.unifesp.br/handle/11600/605
url http://dx.doi.org/10.1590/S0100-72031998000300002
http://repositorio.unifesp.br/handle/11600/605
identifier_str_mv Revista Brasileira de Ginecologia e Obstetrícia. Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, v. 20, n. 3, p. 127-135, 1998.
10.1590/S0100-72031998000300002
S0100-72031998000300002.pdf
0100-7203
S0100-72031998000300002
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Revista Brasileira de Ginecologia e Obstetrícia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 127-135
application/pdf
dc.publisher.none.fl_str_mv Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
publisher.none.fl_str_mv Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1824718309897011200